Wallach M, Grimes DA (eds): Modern Oral Contraception. Updates from he Contraception Report. Totowa, Emron, 2000
Walsh T, Grimes 0, Frezieres R, et al: Randomised controlled trial of prophylactic antibiotics before insertion of intrauterine devices. IUD Study Group. Lancet 351:1005, 1998
Watson: Ella prescribing information. 2010. Available at: http://www.access data. fda.govl drugsatfda_docs/labell20 1 01022474s0001bl.pdf. Accessed
December 27,n2016
Wechselberger G, Wolfram 0, Piilzl P, et al: Nerve injury caused by removal of an implantable hormonal contraceptive. Am J Obstet Gynecol 195(1):323, 2006
Westhof C: IUDs and colonization or infection with Actinomyces. Contraception 75:S48, 2007a
WesthofC, Heartwell S, Edwards S, et al: Initiation of oral contraceptive using a quick start compared with a conventional start: a randomized controlled trial. Obstet Gynecoln109:1270, 2007b
Westhof C, Jain JK, Milson, et al: Changes in weight with depot medroxyprogesterone acetate subcutaneous injection 104 mg/0.65 mL. Contraception 75:261,n2007c
Westhof C, Kerns J, Morroni C, et al: Quick start: novel oral contraceptive initiation method. Contraception 66: 141, 2002
WesthofC, Wieland 0, Tiezzi L: Depression in users of depo-medroxyprogesterone acetate. Contraception 51(6):351,n1995
Westhof CL, T orgal AH, Mayeda ER, et al: Pharmacokinetics of a combined oral contraceptive in obese and normal-weight women. Contraception 81(6):474,n2010
Whitaker AK, Chen BA, Borgatta L: Society of Family Planning Guidelines: postplacental insertion of intrauterine devices. Contraception October 5, 20n17 [Epub ahead of print)
Wilailak S, Vipupinyo C, Suraseranivong V, et al: Depot medroxyprogesterone acetate and epithelial ovarian cancer: a multicentre case-control study. BJOG 119(6):672,2012
World Health Organization: A multinational case-control study of ectopic pregnancy. Clin Reprod Ferriln3:131, 1985
World Health Organization: Acute myocardial infarction and combined oral contraceptives: results of an international multi-center case-control study. Lancet 349:1202, 1997
World Health Organization: Cardiovascular disease and use of oral and injectable progestogen-only contraceptives and combined injectable contraceptives. Resulrs of an international, multicenter, case-control study. Contraception 57:315, 1998
World Healrh Organization: Depot-medroxyprogesterone acetate (DMPA) and risk of endometrial cancer. Int J Cancer 49: 186, 1991a
World Health Organization: Depot-medroxyprogesterone acetate (DMPA) and risk of invasive squamous cell cervical cancer. Contraception 45(4): 299, 1992
World Health Organization: Depot-medroxyprogesterone acetate (DMPA) and risk of liver cancer. Int J Cancer 49(2):182, 1991b